Excellent
Fully Aligned
Patient Risk:
Low
Summary
The claim that safinamide is sold under the brand name Xadago is consistent with the provided label excerpts identifying the product as XADAGO (safinamide).
Category Scores
Accurate Statements
Safinamide is sold under the brand name Xadago.
Label excerpt identifies the product as “XADAGO (safinamide) tablets,” and uses the brand name XADAGO throughout.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
Brand-name identification alone does not introduce safety-relevant dosing or contraindication errors.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement